Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection.
about
Hepatitis C virus infection in the immunocompromised host: a complex scenario with variable clinical impactHepatitis C virus non-structural protein NS3 interacts with LMP7, a component of the immunoproteasome, and affects its proteasome activityCellular RNA helicase p68 relocalization and interaction with the hepatitis C virus (HCV) NS5B protein and the potential role of p68 in HCV RNA replicationInhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon.Lymphocyte subsets in hemophilic patients with hepatitis C virus infection with or without human immunodeficiency virus co-infection: a nested cross-sectional studyTransmission of human hepatitis C virus from patients in secondary cells for long term cultureInvolvement of PKR and RNase L in translational control and induction of apoptosis after Hepatitis C polyprotein expression from a vaccinia virus recombinantHepatitis C virus-associated B-cell non-Hodgkin's lymphomas: what do we know?Extrahepatic manifestations of chronic hepatitis C virus infectionHepatitis C virus and non-Hodgkin's lymphomas: Meta-analysis of epidemiology data and therapy optionsInterferon (IFN) and Cellular Immune Response Evoked in RNA-Pattern Sensing During Infection with Hepatitis C Virus (HCV)Direct effects of hepatitis C virus on the lymphoid cellsHepatitis C virus E2-CD81 interaction induces hypermutation of the immunoglobulin gene in B cells.Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells.Hepatitis C virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6Intrahepatic hepatitis C virus replication correlates with chronic hepatitis C disease severity in vivoDifferent Domains of CD81 Mediate Distinct Stages of Hepatitis C Virus Pseudoparticle EntryHepatitis C Virus Triggers Mitochondrial Permeability Transition with Production of Reactive Oxygen Species, Leading to DNA Damage and STAT3 ActivationEffect of hepatitis C virus core protein on the molecular profiling of human B lymphocytesReplication of Hepatitis C Virus (HCV) RNA in Mouse Embryonic Fibroblasts: Protein Kinase R (PKR)-Dependent and PKR-Independent Mechanisms for Controlling HCV RNA Replication and Mediating Interferon ActivitiesAnalysis of in vitro replicated human hepatitis C virus (HCV) for the determination of genotypes and quasispeciesHepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particlesVirological analysis and phenotypic characterization of peripheral blood lymphocytes of hepatitis C virus-infected patients with and without mixed cryoglobulinaemiaReplication of Hepatitis C Virus Subgenomes in Nonhepatic Epithelial and Mouse Hepatoma CellsHepatitis C Virus Envelope Glycoprotein E2 Glycans Modulate Entry, CD81 Binding, and NeutralizationAntibody-Dependent Enhancement of Hepatitis C Virus InfectionHepatitis C Virus (HCV)-Induced Immunoglobulin Hypermutation Reduces the Affinity and Neutralizing Activities of Antibodies against HCV Envelope ProteinSubcellular forms and biochemical events triggered in human cells by HCV polyprotein expression from a viral vectorCell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cellsHepatitis C Virus Causes Uncoupling of Mitotic Checkpoint and Chromosomal Polyploidy through the Rb PathwayCD81 is an entry coreceptor for hepatitis C virusImmunology of hepatitis B virus and hepatitis C virus infectionCD81 is required for hepatitis C virus glycoprotein-mediated viral infectionHCV infection enhances Th17 commitment, which could affect the pathogenesis of autoimmune diseases.An in vitro model of hepatitis C virion productionProduction of infectious hepatitis C virus by using RNA polymerase I-mediated transcription.Hepatitis C virus protects human B lymphocytes from Fas-mediated apoptosis via E2-CD81 engagementHepatitis C virus entry: molecular mechanisms and targets for antiviral therapy.Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C.Immune control and failure in HCV infection--tipping the balance.
P2860
Q22299128-5572AB6C-FE11-4EE9-989B-D253E85CA2DDQ24300867-8AD6A507-0B4C-4B2E-B0BB-5BD2F8B92CEAQ24338259-FAAA5CD5-DD75-45D5-BCEA-6F777A28D80FQ24519072-E8B23608-93CB-4D38-810E-9F1FB10CA1ADQ24795781-B0C019B3-F8CE-43A1-B6B0-6BE2B152A9DEQ24800686-F01BFE38-CD86-401C-A900-719ACB5AA4C1Q24814549-55C7A2E5-94CC-4359-B223-23A3FFFB7279Q26750997-A683B2CF-1AF9-4582-9AFE-3B9C8432720DQ26767084-7F38C2B8-7C9A-4DB5-B3C0-2024022FD4F1Q26775007-C07F82F4-DCD1-4D62-B0DD-5353A2520692Q26778005-CAEB3184-D4F2-4595-B770-14447AD2622AQ26992142-D3A18D7A-738E-4DA3-9359-4611AC330133Q27469843-8737F97C-3336-48AB-91A0-B23624302B95Q27472707-2756BFC4-2F80-4877-9C2C-D7CCD87733AAQ27472816-33382FCE-D095-4BF3-922D-5BA81ECEC6ACQ27473043-5E592A37-D805-48D0-9F32-25A62822F4BCQ27473222-F55E7EF8-A40F-4F0C-9B25-D84E22F5D388Q27473285-A03B004C-1083-4823-8108-6FC285C2872BQ27473390-33BF7968-3107-4531-8CD4-4F56BD9E28E3Q27477459-871A70A5-4973-459C-B8F9-B9DF15063F70Q27477520-4EAB5608-B82B-43A4-A05A-64AE16403360Q27477687-8054B53E-5A10-4EC4-85C0-4BDB30B2F670Q27478129-9B40AE33-8CEC-4F5C-8CCD-2A8FFCC6C501Q27478415-2839DB3C-1D37-4664-A997-48D32C9F15F0Q27481012-6A54117F-C476-4960-9D15-D8062F360190Q27485451-0744BA85-1CD2-4194-AF2E-9A205315CA7EQ27486411-6C284471-6248-4472-8ED8-7E156C0586DEQ27486946-1EED6D92-470D-4ECF-BECC-8586320F55ABQ27487385-E8C8D3A7-6789-4133-9EA8-7FE304E4136AQ27490465-72A2FE17-9AF0-4A13-9ACC-E56A48483E96Q29614812-E469C4ED-C0A3-49EF-909A-29A51EE6D149Q29618957-B7EFC2A1-BAFE-47DD-ABCE-54DB7A198BCDQ29619745-8062FACB-BC27-4F5C-B85D-92EDBD24BE4BQ33721367-A29BEA69-0C4A-490D-85F4-F492FB1B57D7Q33850594-099B98D3-F209-4262-A485-6879D72474DFQ33877391-76081CB3-7712-46EA-8E1F-32724887EE6BQ33883727-44EB40AC-A63D-4A63-A271-0A8EA90BDF80Q34016463-8FCC7BF3-DDD8-4324-A0CE-279BFA63E740Q34152354-0B870D83-9E57-4AAE-8CF6-B7ABFECF598AQ34178628-B72F83A4-C7B1-4F61-B68B-70DB6DFCB63E
P2860
Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Establishment of B-Cell Lympho ...... tic Effects of Virus Infection
@nl
Establishment of B-cell lympho ...... ic effects of virus infection.
@ast
Establishment of B-cell lympho ...... ic effects of virus infection.
@en
type
label
Establishment of B-Cell Lympho ...... tic Effects of Virus Infection
@nl
Establishment of B-cell lympho ...... ic effects of virus infection.
@ast
Establishment of B-cell lympho ...... ic effects of virus infection.
@en
prefLabel
Establishment of B-Cell Lympho ...... tic Effects of Virus Infection
@nl
Establishment of B-cell lympho ...... ic effects of virus infection.
@ast
Establishment of B-cell lympho ...... ic effects of virus infection.
@en
P2093
P2860
P3181
P1433
P1476
Establishment of B-cell lympho ...... ic effects of virus infection.
@en
P2093
Alexandra M Levine
Alison L Doughty
Gaston R Picchio
Karen L Lindsay
Shigetaka Shimodaira
T S Benedict Yen
Vicky M-H Sung
P2860
P304
P3181
P356
10.1128/JVI.77.3.2134-2146.2003
P577
2003-02-01T00:00:00Z